xlv stock return by quarter 2024

The top 3 holdings of XLV are Eli Lilly and (LLY) (12.187%), UnitedHealth (UNH) (9.23%) and Johnson & Johnson (JNJ) (6.893%).

FUND HOLDING % OF FUND VALUE ($)
XLV
Eli Lilly and (LLY)
12.187%
$4.5B
XLV
UnitedHealth (UNH)
9.23%
$3.4B
XLV
Johnson & Johnson (JNJ)
6.893%
$2.5B
XLV
AbbVie (ABBV)
6.303%
$2.3B
XLV
Merck (MRK)
4.987%
$1.8B
XLV
Thermo Fisher Scientific (TMO)
3.973%
$1.5B
XLV
Abbott Laboratories (ABT)
3.911%
$1.4B
XLV
Intuitive Surgical (ISRG)
3.71%
$1.4B
XLV
Pfizer (PFE)
2.998%
$1.1B
XLV
Danaher (DHR)
2.937%
$1.1B
XLV
Amgen (AMGN)
2.771%
$1B
XLV
Boston Scientific (BSX)
2.619%
$962.8M
XLV
Stryker (SYK)
2.447%
$899.6M
XLV
Bristol-Myers Squibb (BMY)
2.29%
$841.9M
XLV
Gilead Sciences (GILD)
2.276%
$836.7M
XLV
Vertex Pharmaceuticals (VRTX)
2.077%
$763.6M
XLV
Medtronic (MDT)
2.045%
$751.8M
XLV
Elevance Health (ELV)
1.687%
$620.2M
XLV
Cigna (CI)
1.518%
$558.1M
XLV
Regeneron Pharmaceuticals (REGN)
1.497%
$550.3M
XLV
Zoetis (ZTS)
1.458%
$536M
XLV
McKesson (MCK)
1.429%
$525.3M
XLV
Becton Dickinson and (BDX)
1.301%
$478.3M
XLV
CVS Health (CVS)
1.106%
$406.6M
XLV
HCA (HCA)
1.08%
$397M
Holdings are tracked for approximately 2000 ETFs.